Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification

Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification

Background: More accurate risk assessments are needed to improve prostate cancer management. Objective: To identify blood-based protein biomarkers that provided prognostic information for risk stratification. Design, setting, and participants: Mass spectrometry was used to identify biomarker candida...

Full description

Bibliographic Details
Main Authors: Ingrid J. Guldvik, Verena Zuber, Peder R. Braadland, Helene H. Grytli, Håkon Ramberg, Wolfgang Lilleby, Bernd Thiede, Manuela Zucknick, Fahri Saatcioglu, Randi Gislefoss, Rune Kvåle, Anne George, Henrik Grönberg, Fredrik Wiklund, David E. Neal, Vincent J. Gnanapragasam, Kristin A. Taskén, Ian G. Mills
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:European Urology Open Science
Subjects:
Biomarker
Leucine-rich α-2-glycoprotein 1
Noninvasive
Prostate cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320353167

Similar Items

Similar Items